한국어
English
日本語
中文(简体)
Olumiant 2 mg Tablets (Baricitinib)
2mg
Tablet · Prescription medication
Lilly Korea, Ltd.
Baricitinib is a medication that modulates the immune response for the treatment of autoimmune diseases.
MFDS ingredient code M266633
Baricitinib belongs to the Janus kinase (JAK) inhibitor class and is primarily used for the treatment of autoimmune diseases such as rheumatoid arthritis. This ingredient acts as a non-specific immunosuppressant to regulate excessive immune responses.
Baricitinib inhibits the activity of JAK enzymes in the body, blocking the signaling of immune cells. This reduces the immune responses that cause inflammation, alleviating symptoms.
Approved uses differ by product. Check each product's information for its actual use.
Unlike other immunosuppressants, baricitinib selectively inhibits specific JAK enzymes, achieving a balance between efficacy and safety. As a result, the risk of side effects is relatively lower compared to systemic immunosuppression.
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Even with the same ingredient, dosage and approved uses can differ by strength, dosage form and combined ingredients. Check each product's information before taking it.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
Product approval information is based on drug information provided by the Ministry of Food and Drug Safety.
Ingredient and class descriptions are not part of MFDS data and were written separately by Cashdoc.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.
